A Nationwide Population-Based Cohort Study Shows Reduced Hospitalization for Peptic Ulcer Disease Associated With H pylori Eradication and Proton Pump Inhibitor Use

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages 427-431

  Wu, Chun Ying ^a,b,c   Wu, Chia Hsuan ^d   Wu, Ming Shiang ^e   Wang, Chang Bi ^a   Cheng, Jur Shan ^d   Kuo, Ken N ^d   Lin, Jaw Town ^e,f  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH; CLARITHROMYCIN; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DUODENAL ULCER BLEEDING; DUODENUM ULCER; FEMALE; GENDER; GROUPS BY AGE; HELICOBACTER INFECTION; HOSPITAL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERFORATED DUODENAL ULCER; POPULATION RESEARCH; TAIWAN; ULCER PERFORATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIC ULCER; PROTON PUMP INHIBITORS; TAIWAN;

EID: 62849123300     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.029     Document Type: Article

References (19)

1. Roosendaal R., Kuipers E.J., Buitenwerf J., et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 92 (1997) 1480-1482
2. Langman M.J., Weil J., Wainwright P., et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994) 1075-1078
3. Chan F.K., and Leung W.K. Peptic-ulcer disease. Lancet 360 (2002) 933-941
4. Lewis J.D., Bilker W.B., Brensinger C., et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 97 (2002) 2540-2549
5. Lassen A., Hallas J., and Schaffalitzky de Muckadell O.B. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 101 (2006) 945-953
6. Post P.N., Kuipers E.J., and Meijer G.A. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 23 (2006) 1587-1593
7. Kang J.Y., Elders A., Majeed A., et al. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 24 (2006) 65-79
8. Perez-Aisa M.A., Del P.D., Siles M., et al. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 21 (2005) 65-72
9. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology 132 (2007) 2320-2327
10. Kang J.Y., Tinto A., Higham J., et al. Peptic ulceration in general practice in England and Wales 1994-98: period prevalence and drug management. Aliment Pharmacol Ther 16 (2002) 1067-1074
11. Higham J., Kang J.Y., and Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 50 (2002) 460-464
12. Wu C.Y., Wu M.S., Chen Y.J., et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 43 (2007) 799-808
13. Wu M.S., Lee W.J., Wang H.H., et al. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 165 (2005) 1552-1555
14. Cheng T.M. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood) 22 (2003) 61-76
15. Leontiadis G.I., Sharma V.K., and Howden C.W. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay: results from the Cochrane Collaboration. Aliment Pharmacol Ther 22 (2005) 169-174
16. Chong E., and Ensom M.H. Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy 23 (2003) 460-471
17. Schwab M., Schaeffeler E., Klotz U., et al. CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori. Clin Pharmacol Ther 76 (2004) 201-209
18. Cheng S.H., and Chiang T.L. The effect of universal health insurance on health care utilization in Taiwan: results from a natural experiment. JAMA 278 (1997) 89-93
19. Chen L., Yip W., Chang M.C., et al. The effects of Taiwan's National Health Insurance on access and health status of the elderly. Health Econ 16 (2007) 223-242